Skip to main content
Selected G11
G11

Description

The HLC-723G11 is intended for IN VITRO diagnostic use for the quantitative percent determination of hemoglobin A1c (HbA1c) in whole blood samples, in the clinical management of diabetes to assess the long-term efficacy of diabetic control in human subjects, based on the principle of high-performance liquid chromatography. The HLC-723G11 is intended for healthcare Professional Use Only.

Specifications

ANALYTE
Variant Mode: HbA1c (sA1c) β-Thalassemia Mode: HbA2/HbF
Detection Technology
High performance liquid chromatography
Assay Principle
Ion exchange high performance liquid chromatography
Reaction Time (Minutes)
N/A
Assay Time (Minutes)
Variant mode: 60 seconds β-Thalassemia Mode: 5 min
Antibody/Antigen type
N/A
Specimen Volume (uL)
Variant mode: 3 μL β-Thalassemia Mode: 6 μL
Assay Sample
Whole blood K2-EDTA or K3-EDTA
Sample type
Whole Blood / Pre-Diluted Samples
Sample Dimensions
12-15mm diameter, 75-100mm collection tubes
Aspirated Sample Valume
3μL (Var), 6μL (ß-Thal).
Analytical Throughput Variant mode
Variant mode: 1.0 min/sample
ß-Thal Mode
5.0 min/sample

Recently Viewed Items

Back to top